$1.52 Billion is the total value of Bronte Capital Management Pty Ltd.'s 29 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 14.8% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Buy | ISHARES TRcall | $399,441,000 | +16.1% | 177,900 | +14.0% | 26.35% | +4.7% |
| IWO | Buy | ISHARES TRcall | $206,278,000 | +51.8% | 703,900 | +52.1% | 13.61% | +36.9% |
| GOOGL | Sell | ALPHABET INCcap stk cl a | $141,642,000 | +7.7% | 48,892 | -0.6% | 9.34% | -2.9% |
| BRKB | Sell | BERKSHIRE HATHAWAY INC DELcl b new | $124,335,000 | +9.4% | 415,836 | -0.2% | 8.20% | -1.4% |
| HLF | Buy | HERBALIFE NUTRITION LTD | $112,786,000 | +13.5% | 2,755,572 | +17.5% | 7.44% | +2.3% |
| XBI | New | SPDR SER TRcall | $106,160,000 | – | 948,200 | +100.0% | 7.00% | – |
| REGN | Buy | REGENERON PHARMACEUTICALS | $82,388,000 | +9.6% | 130,460 | +5.0% | 5.43% | -1.2% |
| IBKR | Sell | INTERACTIVE BROKERS GROUP | $68,046,000 | +25.6% | 856,785 | -1.4% | 4.49% | +13.3% |
| CTVA | Buy | CORTEVA NC | $41,713,000 | +15.3% | 882,257 | +2.6% | 2.75% | +3.9% |
| V | Buy | VISA INC | $41,466,000 | +4.9% | 191,345 | +7.8% | 2.74% | -5.4% |
| BK | Sell | BANK NEW YORK MELLON CORP | $27,950,000 | +8.3% | 481,240 | -3.3% | 1.84% | -2.3% |
| SPY | Sell | SPDR S&P 500 ETF TRcall | $27,167,000 | -85.1% | 5,700 | -86.6% | 1.79% | -86.6% |
| STT | Sell | STATE STR CORP | $24,624,000 | +8.2% | 264,779 | -1.4% | 1.62% | -2.5% |
| GHC | Buy | GRAHAM HLDGS CO | $18,640,000 | +24.6% | 29,595 | +16.5% | 1.23% | +12.3% |
| GOOG | Sell | ALPHABET INCcap stk cl c | $16,777,000 | -9.7% | 5,798 | -16.8% | 1.11% | -18.6% |
| MO | Sell | ALTRIA GROUP INC | $12,701,000 | -3.0% | 268,018 | -6.8% | 0.84% | -12.5% |
| GIS | Sell | GENERAL MLS INC | $11,345,000 | +12.3% | 168,374 | -0.3% | 0.75% | +1.2% |
| PM | Buy | PHILIP MORRIS INTL INC | $11,119,000 | +10.4% | 117,045 | +10.1% | 0.73% | -0.5% |
| SHC | Buy | SOTERA HEALTH CO | $9,342,000 | +99.3% | 396,667 | +121.3% | 0.62% | +79.6% |
| BYND | BEYOND MEAT INCput | $6,516,000 | -38.1% | 100,000 | 0.0% | 0.43% | -44.2% | |
| MDLZ | Buy | MONDELEZ INTL INCcl a | $5,867,000 | +26.5% | 88,471 | +11.0% | 0.39% | +14.2% |
| Sell | BATH & BODY WORKS INC | $4,116,000 | +9.2% | 58,984 | -1.4% | 0.27% | -1.8% | |
| SQM | New | SOCIEDAD QUIMICA Y MINERA DEspon adr ser b | $3,814,000 | – | 75,627 | +100.0% | 0.25% | – |
| NPO | Sell | ENPRO INDS INC | $3,258,000 | +24.6% | 29,599 | -1.3% | 0.22% | +12.6% |
| NEM | Sell | NEWMONT CORP | $3,025,000 | -23.6% | 48,779 | -33.1% | 0.20% | -31.0% |
| MACK | Sell | MERRIMACK PHARMACEUTICALS IN | $2,102,000 | -20.7% | 537,584 | -2.1% | 0.14% | -28.4% |
| BNTX | Sell | BIONTECH SEsponsored ads | $1,728,000 | -6.8% | 6,702 | -1.4% | 0.11% | -16.2% |
| BYND | New | BEYOND MEAT INC | $969,000 | – | 14,873 | +100.0% | 0.06% | – |
| DBTX | Sell | DECIBEL THERAPEUTICS INC | $731,000 | -40.5% | 157,216 | -1.4% | 0.05% | -46.7% |
| VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -74,920 | -100.0% | -0.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 20 | Q3 2023 | 22.6% |
| ALPHABET INC-CL A | 20 | Q3 2023 | 14.4% |
| HERBALIFE NUTRITION LTD | 20 | Q3 2023 | 22.0% |
| INTERACTIVE BROKERS GROUP | 20 | Q3 2023 | 12.4% |
| ALPHABET INC-CL C | 20 | Q3 2023 | 5.7% |
| VISA INC-CLASS A SHARES | 19 | Q2 2023 | 16.6% |
| CORTEVA NC | 17 | Q3 2023 | 6.2% |
| GRAHAM HOLDINGS CO-CLASS B | 13 | Q3 2023 | 2.1% |
| REGENERON PHARMACEUTICALS | 12 | Q3 2023 | 13.0% |
| STATE STREET CORP | 12 | Q2 2023 | 3.0% |
View Bronte Capital Management Pty Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-13 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-03 |
| 13F-HR/A | 2022-08-08 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-05-13 |
View Bronte Capital Management Pty Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.